−0.6245USD
−2.66 MUSD
51.43 M
About Propanc Biopharma, Inc.
Sector
Industry
CEO
James Andrew Nathanielsz
Website
Headquarters
Camberwell
Founded
2007
ISIN
US74346N6022
FIGI
BBG0020863R5
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm focuses on the treatment of pancreatic, ovarian, and colorectal cancer. It offers its product pipeline, including PRP and POP1. The company was founded by James Nathanielsz and Julian Kenyon on October 15, 2007 and is headquartered in Camberwell, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PPCB is 0.0011 USD — it has increased by 10.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Propanc Biopharma, Inc. stocks are traded under the ticker PPCB.
PPCB stock is 30.00% volatile and has beta coefficient of 3.52. Check out the list of the most volatile stocks — is Propanc Biopharma, Inc. there?
Yes, you can track Propanc Biopharma, Inc. financials in yearly and quarterly reports right on TradingView.
PPCB stock has fallen by 35.29% compared to the previous week, the month change is a 64.52% fall, over the last year Propanc Biopharma, Inc. has showed a 99.63% decrease.
PPCB net income for the last quarter is −584.38 K USD, while the quarter before that showed −350.87 K USD of net income which accounts for −66.55% change. Track more Propanc Biopharma, Inc. financial stats to get the full picture.
Today Propanc Biopharma, Inc. has the market capitalization of 52.14 K, it has decreased by 34.78% over the last week.
No, PPCB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PPCB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Propanc Biopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Propanc Biopharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Propanc Biopharma, Inc. stock shows the sell signal. See more of Propanc Biopharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.